| Title |
Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges
|
|---|---|
| Published in |
Lung Cancer: Targets and Therapy, May 2021
|
| DOI | 10.2147/lctt.s269307 |
| Pubmed ID | |
| Authors |
Toshio Fujino, Kenichi Suda, Tetsuya Mitsudomi |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 17% |
| Italy | 1 | 17% |
| India | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 67 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 8 | 12% |
| Student > Master | 7 | 10% |
| Student > Bachelor | 6 | 9% |
| Researcher | 6 | 9% |
| Student > Ph. D. Student | 5 | 7% |
| Other | 6 | 9% |
| Unknown | 29 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 14 | 21% |
| Biochemistry, Genetics and Molecular Biology | 12 | 18% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Agricultural and Biological Sciences | 3 | 4% |
| Computer Science | 3 | 4% |
| Other | 3 | 4% |
| Unknown | 29 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2023.
All research outputs
#2,148,262
of 25,584,565 outputs
Outputs from Lung Cancer: Targets and Therapy
#6
of 125 outputs
Outputs of similar age
#55,185
of 455,285 outputs
Outputs of similar age from Lung Cancer: Targets and Therapy
#1
of 2 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 125 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,285 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them